Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN133,7133,762,60
Msft372,24372,29-0,32
Nokia7,3787,3962,85
IBM246,28246,46-0,73
Mercedes-Benz Group AG52,6352,71-0,32
PFE28,0228,03-1,04
06.04.2026 19:30:01
Indexy online
AD Index online
select
AD Index online
 

  • 23.03.2026 15:02:36
Prestige Br Hldg (PBH.F, Frankfurt)
Závěr k 2.4.2026 Změna (%) Změna (EUR) Objem obchodů (EUR)
49,20 -1,60 -0,80 8 025
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti

Business Summary: Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Financial Summary: BRIEF: For the nine months ended 31 December 2025, Prestige Consumer Healthcare Inc revenues decreased 4% to $807.1M. Net income decreased 17% to $136.4M. Revenues reflect North American OTC Healthcare-Eye & Ear Care segment decrease of 22% to $92.4M, North American OTC Healthcare-Dermatologicals segment decrease of 6% to $88.2M, International OTC Healthcare-Eye & Ear Care segment decrease of 30% to $12.7M.



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President of the Management BoardPiotr Prajsnar-
Chief Accounting OfficerPiotr Koscianczuk-
Member of the Management BoardPiotr Soleniec-01.03.202101.03.2021